Muhammet Bugra Karaaslan

Muhammet Bugra Karaaslan

Auto-generated profile, based on publicly available information

Muhammet Bugra Karaaslan

Osmancik State Hospital, Turkey

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2021 in International Journal Of Clinical Practice
Verified
Journal Article
Closed access
PDF file
DIDilek İşCan
Dilek İşCan
MKMuhammet Buğra Karaaslan
Muhammet Buğra Karaaslan
ODOnur Sinan Deveci
Onur Sinan Deveci
RARabia Eker Akilli
Rabia Eker Akilli
FKFiliz Koç
Filiz Koç

1 December 2020 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
ÇÖÇağlar Özmen
Çağlar Özmen
ODOnur Sinan Deveci
Onur Sinan Deveci
MKMuhammet Bugra Karaaslan
Muhammet Bugra Karaaslan
OTOya Baydar Toprak
Oya Baydar Toprak
AAAnıl Akray
Anıl Akray
AUAyhan Usal
Ayhan Usal
SUMMARY OBJECTIVE: Early diagnosis and risk stratification may provide a better prognosis in pulmonary embolism (PE). Copeptin has emerged as a valuable predictive biomarker in various cardiovascular diseases. The aim of this study was to determine the levels of copeptin in patients with acute PE and to evaluate its relationship with disease severity and PE-related death. METHODS: Fifty-four patients and 60 healthy individuals were included in this study. Copeptin concentrations and right ventricular dysfunction were analyzed. The correlation between copeptin levels and hemodynamic and echocardiographic parameters was examined. After these first measurements, patients were evaluated with PE-related mortality at the one-year follow-up. RESULTS: The copeptin levels were higher in PE patients than in the control group (8.3 ng/mL vs 3.8 ng/mL, p<0.001). Copeptin levels were found to be significantly higher in patients with PE-related death and right ventricular dysfunction (10.2 vs 7.5 ng/ml, p=0.001; 10.5 vs 7.5 ng/ml, p=0.002, respectively). When the cut-off value of copeptin was ≥5.85, its sensitivity and specificity for predicting PE were 71.9% and 85.0%, respectively (AUC=0.762, 95% CI=0.635-0.889, p<0.001). CONCLUSIONS: The copeptin measurement had moderate sensitivity and specificity in predicting the diagnosis of PE, and the copeptin level was significantly higher in patients with PE-related death at the one-year follow-up. Copeptin may be a useful new biomarker in predicting diagnosis, risk stratification, and prognosis of PE.

1 January 2019 in Indian Pacing and Electrophysiology Journal
Verified
Journal Article
Open access
ACaziz inan Celik
aziz inan Celik
MKMehmet Kanadasi
Mehmet Kanadasi
MDMesut Demir
Mesut Demir
ADAli Deniz
Ali Deniz
RARabia Eker Akilli
Rabia Eker Akilli
MKMuhammet Bugra Karaaslan
Muhammet Bugra Karaaslan
Cryoballoon-based pulmonary vein isolation (PVI) is a treatment option for atrial fibrillation (AF). Left atrial volume (LAV) and left atrial volume index (LAVi) are important parameters for long term success of PVI. Galectin-3 (Gal-3) and neutrophil to lymphocyte ratio (N/L ratio) are biomarkers to demonstrate the cardiac fibrosis and remodelling. 50 patients with symptomatic PAF despite ≥1 antiarrhythmic drug(s), who underwent PVI were enrolled. LAV, LAVi, Gal-3 and N/L ratio were calculated before ablation and after ablation at 6 and 12 months. According to AF recurrence patients were divided into two groups, recurrent AF (n = 14) and non-recurrent AF (n = 36). In both groups (recurrent and non-recurrent), initial and 12 months follow-up LAV values were 41.39 ± 18.13 ml and 53.24 ± 22.11 ml vs 48.85 ± 12.89 ml and 42.08 ± 13.85 (p = 0.037). LAVi were 20.9 ± 8.91 ml/m2 and 26.85 ± 11.28 ml/m2 vs 25.36 ± 6.21 and 21.87 ± 6.66 (p = 0.05) for recurrent and non-recurrent AF groups, respectively. In both groups PVI had no significant effect on serum Gal-3 levels and N/L ratio during 12 months follow-up. The comparison between two groups at the end of 12th month showed Gal-3 values of 6.66 ± 4.09 ng/ml and 6.02 ± 2.95 ng/ml (p = 0.516), N/L ratio values of 2.28 ± 1.07 103/μl and 1.98 ± 0.66 103/μl (p = 0.674). LAV and LAVi are useful to predict the remodelling of the left atrium and AF recurrence after cryoballoon-based PVI. However, biomarkers such as Gal-3 and N/L ratio are not associated with AF recurrence.

1 June 2021 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
ACaziz inan Celik
aziz inan Celik
MKMuhammet Bugra Karaaslan
Muhammet Bugra Karaaslan
OBJECTIVE: Left atrium enlargement is common in hypertension due to left atrium inflammation. Monocyte to high-density lipoprotein cholesterol ratio, an inflammation marker that has become very popular in recent years, is associated with many cardiovascular diseases. The aim of this study is to investigate the monocyte to high-density lipoprotein cholesterol ratio level to predict the Left atrium enlargement in hypertensive patients. METHODS: A total of 216 participants (i.e., 115 hypertensive and 101 control group) were enrolled. Left atrial volumes and left atrial volume indexes were calculated using transthoracic echocardiography. The monocyte to high-density lipoprotein cholesterol ratio was calculated as the ratio of monocyte to high-density lipoprotein cholesterol levels. RESULTS: The left atrial volumes, left atrial volume indexes, and monocyte to high-density lipoprotein cholesterol levels were significantly higher in the hypertensive group than in the control group (43.3 +/- 12.4 versus 31.4 +/- 7.9, p<0.001; 22.9 +/- 5.8 versus 17.1 +/- 3.7, p<0.001; 11.4 [4.2-25.0] versus 8.4 [3.5-18.0], p<0.001, respectively). On the multivariate logistic regression analysis, monocyte to high-density lipoprotein cholesterol ratio (OR 1.38; 95%CI 1.20-1.57; p<0.001), (OR 1.28; 95%CI 1.16-1.42; p<0.001), age, and sex (female) were the independent predictors for hypertension. CONCLUSIONS: The increased monocyte to high-density lipoprotein cholesterol ratio level was associated with hypertension and increased left atrial volume indexes. The results of this study supported the presence of inflammation, measured with a readily available and inexpensive marker, in hypertensive patients and revealed the association with left atrial enlargement.

1 January 2017 in Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
Verified
Journal Article
Open access
MKMuhammet Buğra Karaaslan
Muhammet Buğra Karaaslan
MDMesut Demir
Mesut Demir
Along with the medical technology that has developed in recent years, the elderly population has started to increase all over the world due to the extension of human life. Chronic diseases have been commonly diagnosed with the increasing population of elderly people. Cardiovascular diseases are the most common cause of death in men and women over 65 years of age. High morbidity and mortality due to cardiovascular disease in elderly patients requires effective prevention and treatment in patients. The incidence of cardiovascular diseases is in direct proportion to age; therefore, hypertension, coronary artery disease, carotid artery disease, stroke, heart failure, arrhythmia and valvular diseases can be identified as common cardiovascular diseases in the elderly population.

13 June 2018 in Journal of Clinical and Experimental Investigations
Verified
Journal Article
Open access
PDF file
ADAli Deniz
Ali Deniz
MKMuhammet Bugra Karaaslan
Muhammet Bugra Karaaslan
ACAziz Inan Celik
Aziz Inan Celik
ACAslıgul Cureoglu
Aslıgul Cureoglu
HGHakan Gelincik
Hakan Gelincik
AUAyhan Usal
Ayhan Usal
Years. The incidence of infection has ranged from 0.5 % to 12% in the literature. The purposes of this study was to investigate the frequency of CIED infection and to find the causes of infection. Patients and methods: Totally, 211 patients with CIED infection were retrospectively evaluated. For each patient, all the following data were recorded; age, sex, CIED type, accompanying diseases, complete blood count, serum biochemistry, echocardiographic findings and whether first implantation or replacement. In addition, wound culture, antibiotic regime, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), glomerular filtration rate (GFR) and anticoagulation test results were recorded in infected patients. Results: CIED infection was detected in 18 of the 211 patients (8.5%). 15 cases developed infection following the first implantation (10%), and 3 cases after replacement (5%). Infection was detected within 60 days in 5 patients. CIED pocket cultures were positive in 12 patients (66.7%). 13 of 18 infected devices were removed (72.2%). Diabetes mellitus [Odds Ratio, OR: 4.56 (1.449-14.408)] (p=0.010), male sex [OR: 3.84 (1.034-14.232)] (p=0.045) and increasing age [OR: 0.96 (0.932-0.998)] (p=0.038) were found as significant independent variables on development of CIED; but, pacemaker, implantable cardioverter defibrillator and cardiac resynchronization were not independent variables [OR: 1.66 (0.469-5.929)] (p=0.43). Conclusions: Increasing age, male sex, diabetes mellitus were related to increased frequency of CIED infections. Identification of comorbid conditions prior to CIED implantations may be important in reducing risk of CIED infections.